Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 11/2015

01-11-2015 | Original Article

The self-reported Physical Activity Scale for the Elderly (PASE) is a valid and clinically applicable measure in lung cancer

Authors: Dr. Catherine L Granger, Selina M Parry, Linda Denehy

Published in: Supportive Care in Cancer | Issue 11/2015

Login to get access

Abstract

Purpose

Physical activity (PA) is an important outcome in lung cancer; however, there is lack of consensus as to the best method for assessment. The Physical Activity Scale for the Elderly (PASE) is a commonly used questionnaire. The aim of this study was to assess the clinimetric properties of the PASE in lung cancer, specifically validity, predictive utility and clinical applicability (floor/ceiling effects, responsiveness and minimal important difference [MID]).

Methods

This is a prospective observational study. Sixty-nine participants (62 % male, median [IQR] age 68 years [61–74]) with lung cancer completed the PASE at diagnosis at 2, 4 and 6 months. Additional measures included movement sensors (steps/day), physical function, health-related quality of life, functional capacity (6-min walk distance [6MWD]), and muscle strength. Spearman’s rank correlation coefficient was used to assess relationships. Linear regression analyses were conducted to determine predictive utility of the PASE for health status at 6 months. Responsiveness (effect size) and MID (distribution-based estimation) were calculated.

Results

The PASE was administered on 176 occasions. The PASE had moderate convergent validity with movement sensors (rho = 0.50 [95 %CI = 0.29–0.66], p < 0.005) and discriminated between participants classed as sedentary/insufficient/sufficient according to PA guidelines (p < 0.005). The PASE had fair-moderate construct validity with measures of physical function (rho = 0.57 [95 %CI = 0.46–0.66], p < 0.005), 6MWD (rho = 0.40 [95 %CI = 0.23–0.55], p < 0.005), and strength (rho = 0.37 [95 %CI = 0.18–0.54], p < 0.005). The PASE (at diagnosis) exhibited predictive utility for physical function (Bcoef = 0.35, p = 0.008) and quality of life (Bcoef = 0.35, p = 0.023) at 6 months. A small floor effect was observed (3 %); however, there was no ceiling effect. There was a small responsiveness to change (effect size = 0.23) and MID between 17 and 25 points.

Conclusions

The PASE is a valid measure of self-reported PA in lung cancer.
Appendix
Available only for authorised users
Literature
1.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer http://​globocan.​iarc.​fr, Accessed 10 November 2014
2.
Jones L, Eves N, Haykowsky M, Freedland S, Mackey J (2009) Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 10:598–605CrossRefPubMed
3.
Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y (2002) Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 23:417–423CrossRefPubMed
4.
Schmitz K, Courneya K, Matthews C, Demark-Wahnefried W, Galvao D, Pinto B, Irwin M, Wolin K, Segal R, Lucia A, Schneider C, von Gruenigen V, Schwartz A (2010) ACSM roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426CrossRefPubMed
5.
Coups E, Park B, Feinstein M, Steingart R, Egleston B, Wilson D, Ostroff J (2009) Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life. Cancer Epidemiol Biomarkers Prev 18:664–672PubMedCentralCrossRefPubMed
6.
Granger CL, McDonald CF, Irving L, Clark R, Gough K, Murnane A, Mileshkin L, Krishnasamy M, Denehy L (2014) Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer 83:292–299CrossRefPubMed
7.
Grutsch J, Wood P, Du-Quiton J, Reynolds J, Lis C, Levin R, Ann Daehler M, Gupta D, Quiton D, Hrushesky W (2011) Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer. J Circadian Rhy 9:4–4CrossRef
8.
Granger C, McDonald C, Irving L, Clark RA, Gough K, Murnane A, Mileshkin L, Krishnasamy M, Denehy L (2014) Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer 83:292–299CrossRefPubMed
9.
Westerterp K (2009) Assessment of physical activity: a critical appraisal. Eur J Appl Physiol 105:823–828CrossRefPubMed
10.
de Vet H, Terwee C, Mokkink L, Knol D (2011) Measurement in Medicine—a practical guide. Cambridge University Press
11.
Portney L (2000) Foundations of clinical research applications to practice. Prentice Hall, New Jersey
12.
de Vet H, Terwee C, Ostelo R, Beckerman H, Knol D, Bouter L (2006) Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes. 4
13.
Washburn R, Smith K, Jette A, Janney C (1993) The physical activity scale for the elderly (PASE) - Development and evaluation. J Clin Epidemiol 46:153–162CrossRefPubMed
14.
Forsén L, Loland NW, Vuillemin A, Chinapaw MJM, van Poppel MNM, Mokkink LB, van Mechelen W, Terwee CB (2010) Self-administered Physical Activity Questionnaires for the Elderly: A systematic review of measurement properties. Sports Med 40:601–623CrossRefPubMed
15.
Schuit AJ (1997) Validity of the physical activity scale for the elderly (PASE): According to energy expenditure assessed by the doubly labeled water method. J Clin Epidemiol 50:541–546CrossRefPubMed
16.
Washburn RA (1999) Physical Activity Scale for the Elderly (PASE): the relationship with activity measured by a portable accelerometer. J Sports Med Phys Fitness 39:336–340PubMed
17.
Mokkink L, Terwee C, Knol D, Stratford P, Alonso J, Patrick D, Bouter L, de Vet H (2010) The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 10:22–22PubMedCentralCrossRefPubMed
18.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. BMJ 85:867–872
19.
Granger C, Denehy L, McDonald C, Irving L, Clark R (2014) Physical activity measured using global positioning system tracking in nonsmall cell lung cancer: an observational study. Integr Cancer Ther 13:482–492CrossRefPubMed
20.
Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E, Carbone P (1982) Toxicity And response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed
21.
Washburn RA (2002) The Physical Activity Scale for individuals with physical disabilities: development and evaluation. Arch Phys Med Rehabil 83:193–200CrossRefPubMed
22.
WHO (2010) Global recommendations on physical activity for health. Geneva: World Health Organization. ISBN: 9789241599979:1–58
23.
Webber SC (2009) Monitoring mobility in older adults using Global Positioning System (GPS) watches and accelerometers: a feasibility study. J Aging Phys Act 17:455–467PubMed
24.
Clark R, Weragoda N, Paterson K, Telianidis S, Williams G (2014) A pilot investigation using global positioning systems into the outdoor activity of people with severe traumatic brain injury. J Neuroeng Rehabil. 11
25.
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman S, de Haes J (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed
26.
American Thoracic Society (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef
27.
Colinet B (2005) A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. Br J Cancer 93:1098–1105PubMedCentralCrossRefPubMed
28.
Terwee C, Mokkink L, van Poppel M, Chinapaw M, van Mechelen W, de Vet H (2010) Qualitative attributes and measurement properties of physical activity questionnaires: a checklist. Sports Med 40:525–537CrossRefPubMed
29.
Cohen JW (1988) Statistical power analysis for the behavioral sciences. Lawrence Arlbaum Associates
30.
Husted J, Cook R, Farewell V, Gladman D (2000) Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 53:459–468CrossRefPubMed
31.
Liu RDK, Buffart LM, Kersten MJ, Spiering M, Brug J, van Mechelen W, Chinapaw MJM (2011) Psychometric properties of two physical activity questionnaires, the AQuAA and the PASE, in cancer patients. BMC Med Res Methodol 11:30–30PubMedCentralCrossRefPubMed
32.
Guyatt G, Walter S, Norman G (1987) Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 40:171–178CrossRefPubMed
33.
Walters S, Brazier J (2003) What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes. 1
34.
Prince SA, Adamo KB, Hamel ME, Hardt J, Connor Gorber S, Tremblay M (2008) A comparison of direct versus self-report measures for assessing physical activity in adults: A systematic review. Int J Behav Nutr Phys Act. 5
35.
Terwee C, Bot S, de Boer M, van der Windt D, Knol D, Dekker J, Bouter L, de Vet H (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42CrossRefPubMed
36.
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395CrossRefPubMed
37.
Novoa N, Varela G, Jimenez M, Aranda J (2009) Influence of major pulmonary resection on postoperative daily ambulatory activity of the patients. Interact Cardiovasc Thorac Surg 9:934–938CrossRefPubMed
38.
Guyatt G, Osoba D, Wu A, Wyrwich K, Norman G (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77:371–383CrossRefPubMed
39.
Holland A, Hill C, Rasekaba T, Lee A, Naughton M, McDonald C (2010) Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Am J Phys Med Rehab 91:221–225CrossRef
40.
Lee I, Shiroma E, Lobelo F, Puska P, Blair S, Katzmarzyk P (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380:219–229PubMedCentralCrossRefPubMed
41.
Holmes M, Chen W, Feskanich D, Kroenke C, Colditz G (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486CrossRefPubMed
42.
Meyerhardt J, Giovannucci E, Holmes M, Chan A, Chan J, Colditz G, Fuchs C (2006) Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24:3527–3534CrossRefPubMed
43.
Ibrahim E, Al-Homaidh A (2011) Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol 28:753–765CrossRefPubMed
44.
Granger C, McDonald C, Berney S, Chao C, Denehy L (2011) Exercise intervention to improve exercise capacity and health-related quality of life for patients with non-small cell lung cancer: a systematic review. Lung Cancer 72:139–153CrossRefPubMed
45.
Cavalheri V, Tahirah F, Nonoyama M, Jenkins S, Hill K (2014) Exercise training for people following lung resection for non-small cell lung cancer—a Cochrane systematic review. Cancer Treat Rev. 585–594
46.
Crandall K, Maguire R, Campbell A, Kearney N (2014) Exercise intervention for patients surgically treated for Non-Small Cell Lung Cancer (NSCLC): a systematic review. Surg Oncol 23:17–30CrossRefPubMed
47.
Jones LW, Watson D, Herndon JE 2nd, Eves ND, Haithcock BE, Loewen G, Kohman L (2010) Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer 116:4825–4832CrossRefPubMed
48.
Egan C, Deering B, Blake C, Fullen B, McCormack N, Spruit M, Costello R (2012) Short-term and long-term effects of pulmonary rehabilitation on physical activity in COPD. Respir Med 106:1671–1679CrossRefPubMed
49.
Granger C, McDonald C, Parry S, Oliveira C, Denehy L (2013) Functional capacity, physical activity and muscle strength assessment of individuals with non-small cell lung cancer: a systematic review of instruments and their measurement properties. BMC Cancer. 13
Metadata
Title
The self-reported Physical Activity Scale for the Elderly (PASE) is a valid and clinically applicable measure in lung cancer
Authors
Dr. Catherine L Granger
Selina M Parry
Linda Denehy
Publication date
01-11-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 11/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2707-8

Other articles of this Issue 11/2015

Supportive Care in Cancer 11/2015 Go to the issue

Original Article

Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC)

Original Article

Potential factors associated with perceived cognitive impairment in breast cancer survivors

Original Article

Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer

Original Article

Palliative care in patients with ovarian cancer and bowel obstruction

Original Article

Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy—a survey of health care providers and patients

Original Article

Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits